Compare CYTK & CAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYTK | CAG |
|---|---|---|
| Founded | 1997 | 1919 |
| Country | United States | United States |
| Employees | N/A | 26100 |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 7.5B |
| IPO Year | 2004 | 1994 |
| Metric | CYTK | CAG |
|---|---|---|
| Price | $75.98 | $13.90 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 19 | 17 |
| Target Price | ★ $89.26 | $16.88 |
| AVG Volume (30 Days) | 3.0M | ★ 12.3M |
| Earning Date | 05-05-2026 | 04-01-2026 |
| Dividend Yield | N/A | ★ 9.84% |
| EPS Growth | N/A | ★ 233.33 |
| EPS | N/A | ★ N/A |
| Revenue | $13,368,000.00 | ★ $1,500,000,000.00 |
| Revenue This Year | $7.37 | N/A |
| Revenue Next Year | $310.19 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $29.81 | $13.42 |
| 52 Week High | $80.20 | $23.09 |
| Indicator | CYTK | CAG |
|---|---|---|
| Relative Strength Index (RSI) | 61.72 | 41.60 |
| Support Level | $58.59 | $13.82 |
| Resistance Level | $80.20 | $14.56 |
| Average True Range (ATR) | 3.87 | 0.45 |
| MACD | 0.45 | 0.04 |
| Stochastic Oscillator | 80.49 | 42.73 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Conagra Brands is a packaged food company that operates predominantly in the United States (91% of fiscal 2025 revenue). Most of its revenue comes from frozen food, including brands like Marie Callender's, Healthy Choice, Banquet, and Birds Eye. Conagra also sells snacks, shelf-stable staples, and refrigerated food through brands like Duncan Hines, Hunt's, Slim Jim, Vlasic, Orville Redenbacher's, Reddi-wip, and Wish-Bone. The company primarily sells through the US retail channel, with just 9% of fiscal 2025 revenue coming from international markets and 9% from foodservice.